Telmisartan And Amlodipine Tablet
Product Images NDC 46708-185

9 FDA label images from Alembic Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Telmisartan And Amlodipine (NDC 46708-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Telmiamlo Figure)

Figure (Telmiamlo Figure)
Four line graphs displaying probabilities of achieving target blood pressure levels at Week 8. The top left graph shows the probability of achieving systolic blood pressure under 140 mmHg, the top right under 130 mmHg. The bottom left graph presents the probability of achieving diastolic blood pressure under 90 mmHg, and the bottom right under 80 mmHg. Each graph plots probabilities against baseline blood pressure values for different treatment groups, including Telmisartan and Amlodipine combination and placebo.*
FDA Label Image

Structure (Telmiamlo Telmi)

Structure (Telmiamlo Telmi)
Chemical structure of Telmisartan and Amlodipine shown as a connected molecular diagram with labeled chemical groups including rings, methyl groups, and carboxyl groups.*
FDA Label Image

Structure (Telmiamlo Amlo)

Structure (Telmiamlo Amlo)
Chemical structure diagrams showing two distinct molecules, likely representing the active ingredients in the product Telmisartan and Amlodipine. The left structure features a complex ring with chlorine and ester groups, while the right structure displays a benzene ring with a sulfonic acid group (SO3H).*
FDA Label Image

Tear (Telmiamlo Tear)

Tear (Telmiamlo Tear)
An instructional illustration showing a hand pushing a tablet through the foil of a blister pack. The image demonstrates how to properly remove an oral tablet from its packaging by pressing through the foil backing.*
FDA Label Image

Peal (Telmiamlo Peal)

Peal (Telmiamlo Peal)
An instructional illustration showing hands opening a blister pack to remove an oral tablet. The image demonstrates the proper way to peel back the foil backing from the blister to access a tablet inside.*
FDA Label Image

30 Tablets (Telmiamlo 40 5)

30 Tablets (Telmiamlo 40 5)
Label for Telmisartan and Amlodipine Tablets, USP, 40 mg/5 mg strength. The package contains 30 oral tablets and is manufactured by Alembic Pharmaceuticals Limited. The label includes storage instructions, a barcode, and a note that the package is child-resistant.*
FDA Label Image

30 Tablets (Telmiamlo 40 10)

30 Tablets (Telmiamlo 40 10)
Package label for Telmisartan and Amlodipine Tablets, USP, strength 40 mg/10 mg. The label states there are 30 tablets per package, manufactured by Alembic Pharmaceuticals Limited. Storage instructions and barcode are also visible along with dosage and safety information.*
FDA Label Image

30 Tablets (Telmiamlo 80 5)

30 Tablets (Telmiamlo 80 5)
Label for Telmisartan and Amlodipine Tablets, USP, strength 80 mg/5 mg, oral tablet form. The label states the product contains 30 tablets and is manufactured by Alembic Pharmaceuticals Limited. It includes storage instructions and a barcode, with the NDC number 46708-186-30 clearly visible.*
FDA Label Image

30 Tablets (Telmiamlo 80 10)

30 Tablets (Telmiamlo 80 10)
Label for Telmisartan and Amlodipine Tablets, USP 80 mg/10 mg, oral tablets, packaged 30 tablets per bottle. Manufactured by Alembic Pharmaceuticals Limited. Includes dosage strength, NDC 46708-187-30, barcode, storage instructions, and child-resistant packaging notice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.